Outset Medical insider plans sale of 980 shares

Outset Medical stockholder Marc Nash filed a notice of proposed sale under Rule 144.

Rhea-AI Filing Summary

Outset Medical stockholder Marc Nash filed a notice of proposed sale under Rule 144. He plans to sell 980 shares of common stock through Morgan Stanley Smith Barney LLC on or about 01/21/2026, with an aggregate market value of $4,876.11. The shares are listed on NASDAQ, and the issuer had 18,153,090 shares outstanding at the time stated.

The securities to be sold were acquired on 01/17/2026 via settlement of 14,839 vested restricted stock units as equity compensation for services rendered. Over the prior three months, Nash sold additional common shares, including 247 shares for $1,136.20, 108 shares for $461.16, and 5,375 shares for $27,520.00. By signing the notice, the seller represents that he is not aware of undisclosed material adverse information about the issuer.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Outset Medical (OM) Form 144 filed by Marc Nash disclose?

The filing shows that Marc Nash plans to sell 980 shares of Outset Medical common stock through Morgan Stanley Smith Barney LLC on or about 01/21/2026 on NASDAQ.

How many Outset Medical (OM) shares is Marc Nash planning to sell under this Form 144?

Marc Nash plans to sell 980 shares of Outset Medical common stock, with an indicated aggregate market value of $4,876.11 as disclosed in the notice.

How did Marc Nash acquire the Outset Medical (OM) shares covered by this Form 144?

The shares were acquired on 01/17/2026 through settlement of 14,839 vested restricted stock units, described as equity compensation for services rendered.

What recent Outset Medical (OM) stock sales by Marc Nash are listed in the Form 144?

Over the past three months, the notice lists sales of 247 shares for $1,136.20 on 11/17/2025, 108 shares for $461.16 on 01/07/2026, and 5,375 shares for $27,520.00 on 01/20/2026.

How many Outset Medical (OM) shares were outstanding according to this Form 144?

The notice states that 18,153,090 shares of Outset Medical common stock were outstanding as of the time indicated in the filing.

What representation does the seller make in this Outset Medical (OM) Form 144?

By signing the notice, the seller represents that he does not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/21/2026 - 06:26 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001983815
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Outset Medical, Inc.
SEC File Number	001-39513
Address of Issuer	3052 ORCHARD DRIVE SAN JOSE CALIFORNIA 95134
Phone	669-231-8200
Name of Person for Whose Account the Securities are To Be Sold	Nash Marc
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC 1 New York Plaza, 38th Floor New York NY 10004	980	4876.11	18153090	01/21/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/17/2026	Settlement of Vested Restricted Stock Units	Issuer			14839	01/17/2026	Equity compensation for services rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Marc Nash 3052 Orchard Drive San Jose CA 95134	Common Stock	11/17/2025	247	1136.20
Marc Nash 3052 Orchard Drive San Jose CA 95134	Common	01/07/2026	108	461.16
Marc Nash 3052 Orchard Drive San Jose CA 95134	Common	01/20/2026	5375	27520.00

144: Remarks and Signature

Remarks	Shares sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale was made to satisfy tax withholding obligations through a sell to cover transaction and does not represent a discretionary trade by the reporting person.
Date of Notice	01/21/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	John Brottem POA for Marc Nash
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)